You are here
Vytrus Biotech at 75% of a crowdfunding round of half a million euros
Vytrus Biotech, a member company of CataloniaBio, has opened a round of 550,000 euros on the Capital Cell platform, where InKemia IUCT is the main investor. The crowdfunding campaign ends on 31 October and, to date, the biotechnology company has already obtained 75% of the investment.
Vytrus Biotech is a spin-off of the University of Barcelona and specialises in plant stem cells. In 2014 the company launched its first product on the dermo-cosmetic market and it currently has six of its own products. It has distribution agreements with 50 countries and one of its products has been awarded by the magazine Cosmetics Design for Best Hair Care Ingredient 2017.
The money raised from the crowdfunding round will go towards increasing production capacity, expanding the company’s sales and marketing efforts and continuing to invest in R+D, with a view to obtaining a listing on the MAB (Spanish Alternative Investment Market) in 2018.
Visit the website for more information or to invest in the crowdfunding campaign.